Aytu Biopharma (AYTU) Cash from Investing Activities (2015 - 2025)
Aytu Biopharma (AYTU) reported Cash from Investing Activities of -$17000.0 for Q4 2025, down 111.72% year-over-year from $145000.0 in Q4 2024, and up 99.44% quarter-over-quarter from -$3.0 million in Q2 2025.
Aytu Biopharma (AYTU) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Aytu Biopharma (AYTU) has 11 years of Cash from Investing Activities data on file, last reported at -$17000.0 in Q4 2025.
- Cash from Investing Activities for Q4 2025 came in at -$17000.0, down 111.72% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.0 million (down 817.26% YoY), and the FY2025 annual result was -$2.6 million, down 678.12% from the prior year.
- Cash from Investing Activities advanced to -$17000.0 in Q4 2025 per AYTU's latest filing, from -$3.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $381000.0 in Q3 2024 and troughed at -$3.1 million in Q4 2021.
- A 5-year average of -$483166.7 and a median of -$57000.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2021 and 2024: Cash from Investing Activities tumbled 10070.0% in 2021, then surged 601.32% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$3.1 million in 2021, then jumped by 99.84% to -$5000.0 in 2022, then slumped by 3380.0% to -$174000.0 in 2023, then soared by 183.33% to $145000.0 in 2024, then slumped by 111.72% to -$17000.0 in 2025.
- Business Quant data shows AYTU's Cash from Investing Activities at -$17000.0 in Q4 2025, -$3.0 million in Q2 2025, and -$69000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2025 | -3.02 Mn |
| Mar 31, 2025 | -69,000.00 |
| Mar 31, 2025 | -69,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Dec 31, 2024 | 145,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Sep 30, 2024 | 381,000.00 |
| Jun 30, 2024 | -34,000.00 |
| Jun 30, 2024 | -34,000.00 |
| Mar 31, 2024 | -45,000.00 |
| Mar 31, 2024 | -45,000.00 |
| Dec 31, 2023 | -174,000.00 |
| Dec 31, 2023 | -174,000.00 |
| Sep 30, 2023 | -76,000.00 |
| Sep 30, 2023 | -76,000.00 |
| Jun 30, 2023 | -155,000.00 |
| Jun 30, 2023 | -155,000.00 |